drugset
drugset / Trial / NCT03847987

A 2 Part Study to Assess the Relative Bioavailability of Tablet Formulation Compared to Capsule Formulation and the Effect of Food and Taste Assessment on the Tablet Formulation in Healthy Participants

NCT03847987 ↗

Phase 1 Completed 24 enrolled Hoffmann-La Roche
RandomizedCrossoverOpen-labelTreatment

Summary

This is a two-part, open-label, healthy volunteer study. Part I will investigate the relative bioavailability of capsule and tablet formulations of RO7017773. Part II will explore how the taste of the tablet formulation is perceived with and without added sweetener/flavoring.

Timeline

Start
2019-03-12
Primary completion
2019-04-22
Completion
2019-04-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Alogabat Small molecule — Oral

Indications

No indication recorded.